Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol Hydrochloride Injection Phase III Study in Perioperative Tachyarrhythmias
CTR20254435Phase 3Completed
- Sponsor
- Zhongshan Wanhan Pharmaceutical
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of landiolol in tachyarrhythmia, sponsored by Zhongshan Wanhan Pharmaceutical. Started Dec 2025; status: completed.
02
Drugs
landiolol
03
Conditions
tachyarrhythmia
Beyond the preview
Go deeper on CTR20254435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254435.